Combined c-MET and MEK Inhibition Results in a Synergistic sorted by
relevance

Admin29.09.2021

Combined c-MET and MEK Inhibition Results in a Synergistic

1903
Admin04.09.2021

Combined c-MET and MEK Inhibition Results in a Synergistic

7002
Admin30.07.2021

Combined HDAC and MEK inhibition results in synergistic

Admin19.09.2021

Combined c-MET and MEK inhibition results in apoptosis in

Admin06.10.2021

Therapeutic potential of combined BRAF/MEK blockade in

74010
Admin20.08.2021

Combined MEK and BCL-2/XL Inhibition Is Effective in High

9302
Admin01.08.2021

Combined HDAC and MEK inhibition results in synergistic

63010
Admin23.07.2021

HDAC Inhibition Overcomes Acute Resistance to MEK

Admin01.10.2021

Combination of pan-RAF and MEK inhibitors in NRAS mutant

Admin10.09.2021

Drug combination effects judged by combined synergy

56010
Admin30.07.2021

SHP2 Inhibition Abrogates MEK inhibitor Resistance in

1001
Admin25.07.2021

ADAM-10 and -17 regulate endometriotic cell migration via

7603
Admin25.08.2021

(PDF) Mutant HRAS as novel target for MEK and mTOR inhibitors

9809
Admin18.07.2021

Genomic Status of MET Potentiates Sensitivity to MET and

9701
Admin05.08.2021

SHP2 Inhibition Abrogates MEK inhibitor Resistance in

7105
Admin28.07.2021

MDM2 antagonists synergize broadly and robustly with

808
Admin11.09.2021

(PDF) MEK/MELK inhibition and blood-brain barrier

7403
Admin21.09.2021

Combination of pan-RAF and MEK inhibitors in NRAS mutant

3700
Admin26.09.2021

(PDF) ADAM17-dependent c-MET-STAT3 signaling mediates

407
Admin24.07.2021

(PDF) Combination treatment strategy for pancreatic cancer

9809
Admin25.09.2021

Activation of an early feedback survival loop involving

6108